14.64 USD
+0.07 (+0.48%)
14.8 USD
+0.16 (+1.09%)
Taking everything into account, EMBC scores 6 out of 10 in our fundamental rating. EMBC was compared to 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of EMBC get a neutral evaluation. Nothing too spectacular is happening here. A decent growth rate in combination with a cheap valuation! Better keep an eye on EMBC. With these ratings, EMBC could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
EMBC had positive earnings in the past year.
In the past year EMBC had a positive cash flow from operations.
In the past 5 years EMBC has always been profitable.
Each year in the past 5 years EMBC had a positive operating cash flow.
1.2 Ratios
EMBC's Return On Assets of 7.22% is amongst the best of the industry. EMBC outperforms 88.30% of its industry peers.
EMBC's Return On Invested Capital of 23.87% is amongst the best of the industry. EMBC outperforms 98.94% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EMBC is significantly above the industry average of 8.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.22% | ||
| ROE | N/A | ||
| ROIC | 23.87% |
ROA(3y)10.82%
ROA(5y)28.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)24.33%
ROIC(5y)35.9%
1.3 Margins
The Profit Margin of EMBC (7.58%) is better than 78.72% of its industry peers.
In the last couple of years the Profit Margin of EMBC has declined.
EMBC's Operating Margin of 28.66% is amongst the best of the industry. EMBC outperforms 96.81% of its industry peers.
EMBC's Operating Margin has declined in the last couple of years.
The Gross Margin of EMBC (63.95%) is better than 64.89% of its industry peers.
EMBC's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.66% | ||
| PM (TTM) | 7.58% | ||
| GM | 63.95% |
OM growth 3Y-15.62%
OM growth 5Y-10.93%
PM growth 3Y-41.94%
PM growth 5Y-29.11%
GM growth 3Y-1.58%
GM growth 5Y-1.58%
2. Health
2.1 Basic Checks
EMBC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, EMBC has more shares outstanding
EMBC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for EMBC has been reduced compared to a year ago.
2.2 Solvency
EMBC has an Altman-Z score of 2.00. This is not the best score and indicates that EMBC is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.00, EMBC is in the better half of the industry, outperforming 60.64% of the companies in the same industry.
EMBC has a debt to FCF ratio of 11.34. This is a negative value and a sign of low solvency as EMBC would need 11.34 years to pay back of all of its debts.
EMBC has a better Debt to FCF ratio (11.34) than 71.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 11.34 | ||
| Altman-Z | 2 |
ROIC/WACC3.7
WACC6.45%
2.3 Liquidity
EMBC has a Current Ratio of 2.47. This indicates that EMBC is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of EMBC (2.47) is comparable to the rest of the industry.
EMBC has a Quick Ratio of 1.78. This is a normal value and indicates that EMBC is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.78, EMBC perfoms like the industry average, outperforming 45.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.47 | ||
| Quick Ratio | 1.78 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.88% over the past year.
Measured over the past years, EMBC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -29.06% on average per year.
Looking at the last year, EMBC shows a decrease in Revenue. The Revenue has decreased by -1.47% in the last year.
Measured over the past years, EMBC shows a small growth in Revenue. The Revenue has been growing by 0.25% on average per year.
EPS 1Y (TTM)11.88%
EPS 3Y-42.79%
EPS 5Y-29.06%
EPS Q2Q%51.35%
Revenue 1Y (TTM)-1.47%
Revenue growth 3Y-1.21%
Revenue growth 5Y0.25%
Sales Q2Q%8.44%
3.2 Future
EMBC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.85% yearly.
EMBC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.68% yearly.
EPS Next Y19.34%
EPS Next 2Y10.44%
EPS Next 3Y7.82%
EPS Next 5Y5.85%
Revenue Next Year-2.9%
Revenue Next 2Y-1.46%
Revenue Next 3Y-0.8%
Revenue Next 5Y0.68%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 5.01, which indicates a rather cheap valuation of EMBC.
Based on the Price/Earnings ratio, EMBC is valued cheaper than 97.87% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.65. EMBC is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 4.86 indicates a rather cheap valuation of EMBC.
99.47% of the companies in the same industry are more expensive than EMBC, based on the Price/Forward Earnings ratio.
EMBC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.01 | ||
| Fwd PE | 4.86 |
4.2 Price Multiples
97.34% of the companies in the same industry are more expensive than EMBC, based on the Enterprise Value to EBITDA ratio.
98.94% of the companies in the same industry are more expensive than EMBC, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.47 | ||
| EV/EBITDA | 6.01 |
4.3 Compensation for Growth
EMBC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of EMBC may justify a higher PE ratio.
PEG (NY)0.26
PEG (5Y)N/A
EPS Next 2Y10.44%
EPS Next 3Y7.82%
5. Dividend
5.1 Amount
EMBC has a Yearly Dividend Yield of 4.37%, which is a nice return.
EMBC's Dividend Yield is rather good when compared to the industry average which is at 1.73. EMBC pays more dividend than 99.47% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, EMBC pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.37% |
5.2 History
EMBC has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
41.75% of the earnings are spent on dividend by EMBC. This is a bit on the high side, but may be sustainable.
DP41.75%
EPS Next 2Y10.44%
EPS Next 3Y7.82%
14.64
+0.07 (+0.48%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners101.84%
Inst Owner Change-1.95%
Ins Owners0.46%
Ins Owner Change-0.07%
Market Cap856.29M
Revenue(TTM)1.10B
Net Income(TTM)83.60M
Analysts51.11
Price Target17 (16.12%)
Short Float %4.97%
Short Ratio7.24
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.37% |
Yearly Dividend0.6
Dividend Growth(5Y)N/A
DP41.75%
Div Incr Years0
Div Non Decr Years2
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.83%
Min EPS beat(2)29.98%
Max EPS beat(2)41.68%
EPS beat(4)4
Avg EPS beat(4)34.39%
Min EPS beat(4)21.87%
Max EPS beat(4)44.01%
EPS beat(8)8
Avg EPS beat(8)41.88%
EPS beat(12)10
Avg EPS beat(12)32.96%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.06%
Min Revenue beat(2)-0.01%
Max Revenue beat(2)4.13%
Revenue beat(4)3
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-0.01%
Max Revenue beat(4)4.13%
Revenue beat(8)6
Avg Revenue beat(8)2.11%
Revenue beat(12)10
Avg Revenue beat(12)2.35%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.01 | ||
| Fwd PE | 4.86 | ||
| P/S | 0.78 | ||
| P/FCF | 6.47 | ||
| P/OCF | 6.38 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.01 |
EPS(TTM)2.92
EY19.95%
EPS(NY)3.01
Fwd EY20.58%
FCF(TTM)2.26
FCFY15.45%
OCF(TTM)2.3
OCFY15.68%
SpS18.85
BVpS-11.45
TBVpS-11.84
PEG (NY)0.26
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.22% | ||
| ROE | N/A | ||
| ROCE | 35.84% | ||
| ROIC | 23.87% | ||
| ROICexc | 32.32% | ||
| ROICexgc | 33.49% | ||
| OM | 28.66% | ||
| PM (TTM) | 7.58% | ||
| GM | 63.95% | ||
| FCFM | 12% |
ROA(3y)10.82%
ROA(5y)28.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)24.33%
ROIC(5y)35.9%
ROICexc(3y)39.2%
ROICexc(5y)44.82%
ROICexgc(3y)41.18%
ROICexgc(5y)47.17%
ROCE(3y)36.53%
ROCE(5y)53.9%
ROICexgc growth 3Y-18.01%
ROICexgc growth 5Y-11.68%
ROICexc growth 3Y-17.5%
ROICexc growth 5Y-11.4%
OM growth 3Y-15.62%
OM growth 5Y-10.93%
PM growth 3Y-41.94%
PM growth 5Y-29.11%
GM growth 3Y-1.58%
GM growth 5Y-1.58%
F-Score6
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 11.34 | ||
| Debt/EBITDA | 4.21 | ||
| Cap/Depr | 5.39% | ||
| Cap/Sales | 0.18% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 38.03% | ||
| Profit Quality | 158.25% | ||
| Current Ratio | 2.47 | ||
| Quick Ratio | 1.78 | ||
| Altman-Z | 2 |
F-Score6
WACC6.45%
ROIC/WACC3.7
Cap/Depr(3y)66.88%
Cap/Depr(5y)82.76%
Cap/Sales(3y)1.97%
Cap/Sales(5y)2.62%
Profit Quality(3y)85.85%
Profit Quality(5y)92.96%
High Growth Momentum
Growth
EPS 1Y (TTM)11.88%
EPS 3Y-42.79%
EPS 5Y-29.06%
EPS Q2Q%51.35%
EPS Next Y19.34%
EPS Next 2Y10.44%
EPS Next 3Y7.82%
EPS Next 5Y5.85%
Revenue 1Y (TTM)-1.47%
Revenue growth 3Y-1.21%
Revenue growth 5Y0.25%
Sales Q2Q%8.44%
Revenue Next Year-2.9%
Revenue Next 2Y-1.46%
Revenue Next 3Y-0.8%
Revenue Next 5Y0.68%
EBIT growth 1Y38.48%
EBIT growth 3Y-16.64%
EBIT growth 5Y-10.7%
EBIT Next Year38.7%
EBIT Next 3Y10.75%
EBIT Next 5Y8.14%
FCF growth 1Y88.46%
FCF growth 3Y-63.73%
FCF growth 5Y-46.06%
OCF growth 1Y39.75%
OCF growth 3Y-57.22%
OCF growth 5Y-41.13%
EMBECTA CORP / EMBC FAQ
What is the fundamental rating for EMBC stock?
ChartMill assigns a fundamental rating of 6 / 10 to EMBC.
Can you provide the valuation status for EMBECTA CORP?
ChartMill assigns a valuation rating of 9 / 10 to EMBECTA CORP (EMBC). This can be considered as Undervalued.
What is the profitability of EMBC stock?
EMBECTA CORP (EMBC) has a profitability rating of 6 / 10.
What is the valuation of EMBECTA CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for EMBECTA CORP (EMBC) is 5.01 and the Price/Book (PB) ratio is -1.28.
Can you provide the dividend sustainability for EMBC stock?
The dividend rating of EMBECTA CORP (EMBC) is 5 / 10 and the dividend payout ratio is 41.75%.